Active Ingredient : SLU-PP-332 (Quantity as per selected variant) Inactive Ingredients : Excipients Bottle of 100 tablets Test Certificate: Provided for quality confirmation SLU-PP-332 5 out of 5 based on 1 customer rating EUR 142.64 EUR 142.64 EUR 142.64 sample SLU32 is a research-grade ERR agonist available in tablet form at 250 mcg, 500 mcg, and 1 mg strength options
Available in-office or through convenient at-home self-injection kits, these therapies can help support energy, metabolism, recovery, immune function, and overall wellness with physician-guided protocols tailored to your needs
Previous work revealed an upregulation of activated T cells up to 8 months after infection 36
Obesity and dysregulated lipid homeostasis are connected to increased risk of breast cancer and correlate with worse outcomes in both breast and ovarian cancers [3,4,5], and increased cholesterol levels in cancer cells correlate with their increased growth, invasiveness and chemoresistance [6,7,8]